Edwards Lifesciences Corp (EW)

Net profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net income (ttm)	US$ in thousands	1,402,400	1,430,900	1,389,500	1,488,800	1,521,900	1,458,800	1,455,400	1,538,500	1,503,100	2,063,200	2,048,300	1,436,900	1,409,300	1,401,800	1,351,300	1,715,500	1,654,600	1,689,700	1,640,900	1,681,300
Revenue (ttm)	US$ in thousands	5,997,700	5,823,000	5,652,900	5,488,400	5,362,000	5,360,300	5,343,800	5,344,000	5,219,100	5,093,000	4,925,300	4,477,100	4,393,400	4,375,800	4,330,900	4,493,400	4,355,200	4,158,800	3,968,100	3,822,500
Net profit margin		23.38%	24.57%	24.58%	27.13%	28.38%	27.21%	27.24%	28.79%	28.80%	40.51%	41.59%	32.09%	32.08%	32.04%	31.20%	38.18%	37.99%	40.63%	41.35%	43.98%

December 31, 2023 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $1,402,400K ÷ $5,997,700K
= 23.38%

The net profit margin of Edwards Lifesciences Corp has shown a downward trend over the past four quarters. From Q1 2022 to Q4 2023, the net profit margin decreased from 28.72% to 23.35%. This decline indicates that the company's profitability relative to its revenue has been decreasing over time.

Although the net profit margins for Q2 and Q3 2023 remained relatively stable at around 24.5%, there was a more significant drop in Q4 2023 down to 23.35%, the lowest level in the given periods. This decrease in net profit margin may raise concerns about the company's ability to efficiently convert its sales into profits.

The fluctuation in net profit margin could be influenced by various factors such as changes in costs, pricing strategies, or operating efficiency. Further analysis of the company's financial performance and operational strategies would be necessary to understand the reasons behind this downward trend in net profit margin and to assess its potential implications for the company's overall financial health.